Dr. Gill is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4945 W Cypress Ave
Visalia, CA 93277Phone+1 559-624-3100Fax+1 812-376-5930
Education & Training
- University of Louisville School of MedicineFellowship, Hematology and Medical Oncology, 2016 - 2019
- Sinai Hospital of BaltimoreChief Residency, Internal Medicine, 2015 - 2016
- Sinai Hospital of BaltimoreResidency, Internal Medicine, 2012 - 2016
- Christian Medical College LudhianaClass of 2010
Certifications & Licensure
- CA State Medical License 2024 - 2026
- IN State Medical License 2019 - 2025
- KY State Medical License 2016 - 2020
- MD State Medical License 2015 - 2016
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Winner, National Abstract competition ACP, 2014
- Young Achiever, Honorary Title ACP, 2014
- Distinction in Anatomy Dissection Competition, Dept of Anatomy Christian Medical College, 2005
- Join now to see all
Publications & Presentations
PubMed
- 1 citations5-(3,3-Dimethyle-1-Triazeno) Imidazole-4-Carboxamide and Interleukin-2 Adjuvant Therapy in Resected High-Risk Primary and Regionally Metastatic Melanoma.Amitoj Gill, Rahul Gosain, Hana Gragg, Ryan Bycroft, Shesh N. Rai
The American Journal of the Medical Sciences. 2019-01-01 - 15 citationsRadioactive Iodine-Refractory Differentiated Thyroid Cancer in the Elderly.Rohit Gosain, Jonathan S Alexander, Amitoj Gill, Cesar A. Perez
Current Oncology Reports. 2018-09-11 - 24 citationsManagement of immunotherapy toxicities in older adults.Shruti Bhandari, Amitoj Gill, Cesar A. Perez, Dharamvir Jain
Seminars in Oncology. 2018-08-01
Journal Articles
- Use of the word "death" in cancer careA. Gill, S. Bhandari, R. Gosain, J. Abraham, S. Terwindt, R. Stephan, K. Miller, Journal of Clinical Oncology, 1/1/2014
- Do patients need lifelong follow-up? Why?R. Gosain S. Bhandari, A. Gill, M. Befikadu, J. Abraham, S. Terwindt, K. Miller, Journal of Clinical Oncology, 1/1/2014
- Refractive errors in school children: A review from PunjabN. Batra, D. Kaushal, A. Gill, National Program for control of blindness quarterly, 1/1/2007
Books/Book Chapters
Abstracts/Posters
- Role of neutrophil to lymphocyte ratio in addition to revised international prognostic index (R-IPI) in patients with extranodal diffuse large B-cell lymphoma of head ...Cisak KI, Gill A, Faber E, Redman RA, Dunlap NE, Rai S, Wu X, Perez CA, J Clin Oncol, 1/1/2017
- Clinicopathological presentation of extranodal lymphomas of head and neck: A single institution experience over the last decade.Gill A, Cisak KI, Gosain R, Perez CA, J Clin Oncol, 1/1/2017
- Interleukin-2 (IL-2) and 5-(3,3-dimethyle-1-triazeno) imidazole-4-carboxamide (DTIC) for adjuvant therapy in resected high-risk primary and regionally metastatic melan...Rahul Gosain, Amitoj Gill, Hana Gragg, Ryan Glenn Bycroft, Shesh Rai, Jianmin Pan, Jason Alan Chesney, and Donald M. Miller, Journal of Clinical Oncology, 1/1/2017
- Join now to see all
Press Mentions
- CRH Welcomes Two Specialty PhysiciansJuly 27th, 2019
- Marketplace: CRH Welcomes Two New PhysiciansJuly 26th, 2019
Professional Memberships
- Member
- Member
Other Languages
- Hindi, Punjabi, Urdu
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: